Liver fluke is known to cause severe clinical disease and death, costing the sheep industry alone millions of pounds every year. Now spreading to new regions liver fluke can increasingly be found throughout the UK, largely due to the impact of climate change. All these factors favour liver fluke:
Due to this lengthening of seasons, and the impact of warm, wet weather on the liver fluke lifecycle, the liver fluke challenge can now be higher for a longer period with the risk of high fluke burdens in both sheep and cattle extending throughout the year if not treated effectively.
Resistance to certain active ingredients has been identified on a number of farms. Once liver fluke have become resistant to an active ingredient, and can survive exposure to a treatment that would normally kill them, there is no evidence to suggest they will return to susceptibility. As individuals, and as an industry, we can’t afford to allow this to happen. To achieve effective control now – and to preserve the efficacy of the existing active ingredients for the future – we need to adopt a new approach to liver fluke management. 4 elements of sustainable liver fluke control:
Fasinex® 5% Oral Suspension for sheep contains 5% (w/v) triclabendazole and is indicated for the treatment and control of liver fluke infections in sheep caused by all stages of triclabendazole susceptible Fasciola hepatica from 2 day old immature to adult fluke.
Fasimec® Duo Oral Suspension for sheep contains 0.1% (w/v) ivermectin and 5% (w/v) triclabendazole and is indicated for the treatment of mixed trematode (fluke) and nematode or arthropod infections due to gastrointestinal roundworms, lungworms, liver fluke and nasal bots.
Combinex® Oral Suspension for sheep contains 3.75% (w/v) levamisole hydrochloride and 5% (w/v) triclabendazole and is indicated For the treatment and control of parasitic bronchitis, parasitic gastro-enteritis and fascioliasis in sheep. When used at the recommended dose rate, the product is effective against mature and developing immature stages of levamisole-susceptible Haemonchus, Ostertagia, Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Chabertia and Oesophagostomum species in the gastro-intestinal tract, and Dictyocaulus spp in the lungs. It is also effective against all stages of Triclabendazole susceptible Fasciola hepatica from two day old early immature to adult fluke, and so is indicated against both acute and chronic fascioliasis.
Flukiver® 5% w/v Oral Suspension contains 50mg/ml closantel and is indicated for the control of chronic and subacute fascioliasis (due to Fasciola hepatica) in sheep and lambs. For the control of Oestrus ovis (Sheep Nasal Bot Fly). For the control of inhibited, immature and adult stages of Haemonchus contortus (Barber Pole Worm) including benzimidazole resistant strains. Flukiver is active against mature and immature flukes.
Supaverm® Oral Suspension contains 5% w/v closantel and 7.5% w/v mebendazole and is indicated for the control of fascioliasis (due to Fasciola hepatica) and gastrointestinal nematodes and cestodes in sheep and lambs. The combination is active against lungworm, roundworms, tapeworms (heads and segments) and fluke (mature and immature). The control of the larval stages of Oestrus ovis (Sheep Nasal Bot fly), and the control of inhibited, immature and adult stages of Haemonchus contortus (Barber Pole worm) including benzimidazole resistant strains.
Legal category for all: POM-VPS.
Information regarding the side effects, precautions, warnings and contra-indications can be found in product packaging and leaflets; further information can also be found in the Summary of Product Characteristics.
Fasinex®, Fasimec® Duo, Combinex®, Flukiver®, Supaverm®, Elanco™ and the diagonal bar™ logo are trademarks of Elanco or its affiliates. Use medicines responsibly (www.noah.co.uk/responsible). Advice should be sought from the prescriber prior to use.